Nevertheless, it is plausible that the potent anti-stemness effects observed by targeting EGFR, IGFR, and PDGFR pathways could also be due to a direct effect on the tumor cells, since these signaling pathways are frequently altered in different cancers, including HNSCC. The gene discussed is IGF1R; the disease is neoplasm.